Treatment of cerebellar ataxia

Tracy M. Jones; Jessica D. Shaw; Kelly L. Sullivan; Theresa A. Zesiewicz

doi:10.2217/nmt.14.27

Treatment of cerebellar ataxia

Tracy M. Jones
, Jessica D. Shaw
, Kelly L. Sullivan
, Theresa A. Zesiewicz

Biostatistics, Epidemiology & Environmental Health Sciences

University of South Florida

Research output: Contribution to journal › Systematic review › peer-review

8 Scopus citations

Abstract

Symptoms of cerebellar degeneration include ataxia or wide-based gait, visual and speech dysfunction, dysmetria, and dyscoordination. The etiology of cerebellar degeneration is vast and often complex, and requires neuroimaging, lab assessments, and a thorough family history to delineate its cause. There is currently no accepted treatment of hereditary cerebellar degeneration, although several pharmaceutical agents have shown potential promise.

Original language	English
Pages (from-to)	379-392
Number of pages	14
Journal	Neurodegenerative Disease Management
Volume	4
Issue number	5
DOIs	https://doi.org/10.2217/nmt.14.27
State	Published - 2014

Scopus Subject Areas

Clinical Neurology

Keywords

ataxia
cerebellar degeneration

Access to Document

10.2217/nmt.14.27License: Unspecified

Cite this

@article{a04d7d94c4404a3f850abd95ad9ebd10,

title = "Treatment of cerebellar ataxia",

abstract = "Symptoms of cerebellar degeneration include ataxia or wide-based gait, visual and speech dysfunction, dysmetria, and dyscoordination. The etiology of cerebellar degeneration is vast and often complex, and requires neuroimaging, lab assessments, and a thorough family history to delineate its cause. There is currently no accepted treatment of hereditary cerebellar degeneration, although several pharmaceutical agents have shown potential promise.",

keywords = "ataxia, cerebellar degeneration",

author = "Jones, \{Tracy M.\} and Shaw, \{Jessica D.\} and Sullivan, \{Kelly L.\} and Zesiewicz, \{Theresa A.\}",

note = "Symptoms of cerebellar degeneration include ataxia or wide-based gait, visual and speech dysfunction, dysmetria, and dyscoordination. The etiology of cerebellar degeneration is vast and often complex, and requires neuroimaging, lab assessments, and a thorough family history to delineate its cause. There is currently no accepted treatment of hereditary cerebellar degeneration, although several pharmaceutical agents have shown potential promise.",

year = "2014",

doi = "10.2217/nmt.14.27",

language = "English",

volume = "4",

pages = "379--392",

journal = "Neurodegenerative Disease Management",

issn = "1758-2024",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Treatment of cerebellar ataxia

AU - Jones, Tracy M.

AU - Shaw, Jessica D.

AU - Sullivan, Kelly L.

AU - Zesiewicz, Theresa A.

N1 - Symptoms of cerebellar degeneration include ataxia or wide-based gait, visual and speech dysfunction, dysmetria, and dyscoordination. The etiology of cerebellar degeneration is vast and often complex, and requires neuroimaging, lab assessments, and a thorough family history to delineate its cause. There is currently no accepted treatment of hereditary cerebellar degeneration, although several pharmaceutical agents have shown potential promise.

PY - 2014

Y1 - 2014

N2 - Symptoms of cerebellar degeneration include ataxia or wide-based gait, visual and speech dysfunction, dysmetria, and dyscoordination. The etiology of cerebellar degeneration is vast and often complex, and requires neuroimaging, lab assessments, and a thorough family history to delineate its cause. There is currently no accepted treatment of hereditary cerebellar degeneration, although several pharmaceutical agents have shown potential promise.

AB - Symptoms of cerebellar degeneration include ataxia or wide-based gait, visual and speech dysfunction, dysmetria, and dyscoordination. The etiology of cerebellar degeneration is vast and often complex, and requires neuroimaging, lab assessments, and a thorough family history to delineate its cause. There is currently no accepted treatment of hereditary cerebellar degeneration, although several pharmaceutical agents have shown potential promise.

KW - ataxia

KW - cerebellar degeneration

UR - https://www.scopus.com/pages/publications/84936080753

U2 - 10.2217/nmt.14.27

DO - 10.2217/nmt.14.27

M3 - Systematic review

SN - 1758-2024

VL - 4

SP - 379

EP - 392

JO - Neurodegenerative Disease Management

JF - Neurodegenerative Disease Management

IS - 5

ER -

Treatment of cerebellar ataxia

Abstract

Scopus Subject Areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this